Jazz Pharmaceuticals plc
JAZZ
$167.10
$0.390.23%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.05B | 1.67B | 2.57B | 2.99B | 2.62B |
| Total Receivables | 764.36M | 714.00M | 652.99M | 716.77M | 723.64M |
| Inventory | 483.11M | 504.99M | 492.78M | 480.45M | 539.30M |
| Prepaid Expenses | 146.89M | 164.00M | 150.28M | 177.41M | 155.13M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 315.44M | 297.55M | 259.79M | 260.58M | 354.20M |
| Total Current Assets | 3.76B | 3.35B | 4.13B | 4.63B | 4.39B |
|
|
|||||
| Total Current Assets | 3.76B | 3.35B | 4.13B | 4.63B | 4.39B |
| Net Property, Plant & Equipment | 250.12M | 248.06M | 228.05M | 227.00M | 253.59M |
| Long-term Investments | 1.83B | 1.84B | 1.76B | 1.72B | 1.80B |
| Goodwill | 1.83B | 1.84B | 1.76B | 1.72B | 1.80B |
| Total Other Intangibles | 4.57B | 4.77B | 4.72B | 4.76B | 5.14B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 952.97M | 728.39M | 696.31M | 679.88M | 658.54M |
| Total Assets | 11.36B | 10.94B | 11.53B | 12.01B | 12.26B |
|
|
|||||
| Total Accounts Payable | 152.23M | 89.37M | 95.93M | 77.87M | 85.43M |
| Total Accrued Expenses | 853.76M | 820.56M | 840.97M | 821.98M | 805.32M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.04B | 1.04B | 44.44M | 45.78M | 50.68M |
| Total Finance Division Other Current Liabilities | 224.56M | 118.92M | 241.27M | 92.94M | 88.56M |
| Total Other Current Liabilities | 224.56M | 118.92M | 241.27M | 92.94M | 88.56M |
| Total Current Liabilities | 2.27B | 2.07B | 1.22B | 1.04B | 1.03B |
|
|
|||||
| Total Current Liabilities | 2.27B | 2.07B | 1.22B | 1.04B | 1.03B |
| Long-Term Debt | 4.33B | 4.34B | 5.34B | 6.08B | 6.08B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 53.43M | 55.11M | 38.78M | 43.50M | 71.12M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 737.95M | 775.85M | 761.76M | 758.79M | 900.35M |
| Total Liabilities | 7.40B | 7.24B | 7.36B | 7.92B | 8.08B |
|
|
|||||
| Common Stock & APIC | 4.09B | 4.00B | 3.93B | 3.91B | 3.84B |
| Retained Earnings | 442.73M | 191.31M | 1.03B | 1.13B | 936.23M |
| Treasury Stock & Other | -569.37M | -485.24M | -785.08M | -947.14M | -602.87M |
| Total Common Equity | 3.96B | 3.71B | 4.17B | 4.09B | 4.17B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.96B | 3.71B | 4.17B | 4.09B | 4.17B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.96B | 3.71B | 4.17B | 4.09B | 4.17B |
|
|
|||||